BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 2, 2008
View Archived Issues
Recent patents cover new agents for endocrine disorders
Read More
Novel agents with possible use in obesity and other metabolic disorders described in recent patents
Read More
Radiosensitization seen with CEP-9722 in radioresistant glioblastoma xenografts
Read More
Eg5 kinesin inhibitor with cytotoxic activity discovered at ArQule
Read More
Destiny Pharma's XF-73 demonstrates activity against Gram-positive bacteria
Read More
Compugen discovers blood-based biomarker for diagnosis of lung cancer
Read More
DOR BioPharma initiates nonhuman primate efficacy studies of RiVax ricin toxin vaccine
Read More
Genentech and Biogen report negative results from phase II/III study of Rituxan in SLE
Read More
Insmed presents development update on Iplex and the follow-on biologics INS-19 and INS-20
Read More
Antisoma presents update on clinical development activities of its anticancer compounds
Read More
Alexza reports positive results from phase I clinical trial of Staccato for insomnia
Read More
Recent Pfizer and AstraZeneca patents disclose new treatment options for respiratory disorders
Read More
Safe delivery of gene therapy for the treatment of retinal dystrophy
Read More
Resolvin E1 analogues improve dry eye symptoms and may be suitable for other ocular disorders
Read More
AstraZeneca submits sNDA for Symbicort for COPD
Read More
MediQuest submits NDA to FDA to treat Raynaud's disease
Read More
SkyePharma presents positive phase III efficacy data for Flutiform
Read More
Regression of CNV with novel pan-tubulin inhibitor OC-10X
Read More
Merck Serono and ZymoGenetics initiate phase II clinical trial of atacicept in RMS
Read More
Partial efficacy of Merck & Co.'s novel SSTR2 antagonists in models of CNV
Read More
Lundbeck obtains expanded rights from Neurim to commercialize Circadin outside of E.U.
Read More
ISTA Pharmaceuticals presents new phase III clinical findings to support Bepreve NDA
Read More
FDA approves Advair 250/50 for reduction of exacerbations in COPD patients
Read More
Innocoll initiates dosing in phase II clinical trial of CollaRx gentamicin topical sponge
Read More
